Archives

SurplusGLOBAL’s SemiMarket Attracts More Than 40 Global Buyers in First Online Semiconductor Equipment Auction, Driving 70% Higher Selling Prices

B SEOUL, South Korea, May 18, 2026 /PRNewswire/ — SemiMarket, the semiconductor equipment and parts marketplace operated by SurplusGLOBAL, announced the results of its first Online Bidding event, highlighting growing…

Read MoreSurplusGLOBAL’s SemiMarket Attracts More Than 40 Global Buyers in First Online Semiconductor Equipment Auction, Driving 70% Higher Selling Prices

Bio-Thera Solutions’ Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States

B GUANGZHOU, China, May 18, 2026 /PRNewswire/ — Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty…

Read MoreBio-Thera Solutions’ Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States

Pending Class Action Lawsuit Involving the Purchase and/or Acquisition of Evolv Technologies Holdings, Inc. Common Stock Between June 28, 2021 and October 25, 2024

B BOSTON, May 18, 2026 /PRNewswire/ —  UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS IN RE EVOLV TECHNOLOGIES HOLDINGS INC. SECURITIES LITIGATION Case No. 1:24-cv-10761-ADB SUMMARY NOTICE OF (I) PENDENCY…

Read MorePending Class Action Lawsuit Involving the Purchase and/or Acquisition of Evolv Technologies Holdings, Inc. Common Stock Between June 28, 2021 and October 25, 2024